Fundraising FoxTramway Venture Partners — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.
AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US
Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)
Board seatWaneta Tuttle· per SEC Form D
Co-investorsCottonwood Technology FundMountain Group Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.